The mass spectrometry proteomics data associated of TauRD-Y interactome from TauRD-Y and TauRD-Y* cells.

By Itika Saha, PhD, Patricia Yuste Checa, PhD, Miguel Da Silva Padilha, Qiang Guo, Roman Körner, Hauke Holthusen, Victoria Anne Trinkaus, MSc, Irina Dudanova, Ruben Fernandez-Busnadiego, PhD, Wolfgang Baumeister, David W. Sanders, Saurabh Gautam, Marc I. Diamond, Franz-Ulrich Hartl, MD and Mark S. Hipp
View Published Dataset

Output Details

Description

The mass spectrometry proteomics data associated to Fig. 2a have been deposited to the ProteomeXchange Consortium via the PRIDE84 partner repository (https://www.ebi.ac.uk/pride/archive/) with the dataset identifier PXD023400 Associated with the following preprint: Saha et al., 2022 (published on biorxiv on Feb 19th, 2022) https://www.biorxiv.org/content/10.1101/2022.02.18.481043v1.full

Tags
  • Human
  • Mass spectrometry
  • Protein
Team
Team Harper
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

  • Itika Saha, PhD

    Key Personnel: Team Harper, 

    Max Planck Institute of Biochemistry

  • Patricia Yuste Checa, PhD

    Key Personnel: Team Harper, 

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Miguel Da Silva Padilha

  • User avatar fallback logo

    Qiang Guo

  • User avatar fallback logo

    Roman Körner

  • User avatar fallback logo

    Hauke Holthusen

  • Victoria Anne Trinkaus, MSc

    Key Personnel: Team Harper, 

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Irina Dudanova

  • Ruben Fernandez-Busnadiego, PhD

    Co-PI (Core Leadership): Team Harper, 

    University of Gottingen

  • User avatar fallback logo

    Wolfgang Baumeister

  • User avatar fallback logo

    David W. Sanders

  • User avatar fallback logo

    Saurabh Gautam

  • User avatar fallback logo

    Marc I. Diamond

  • Franz-Ulrich Hartl, MD

    Co-PI (Core Leadership): Team Harper, 

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Mark S. Hipp

Related Research

L1-silenced iPSC line (HS1_L1HS-CRISPRi_g1)

Human iPSCs were modified with CRISPRi to target LINE-1 retrotransposons, creating stable cell lines with different genetic backgrounds and guide RNAs. These resources are detailed in Adami et al. (DOI: 10.1016/j.xgen.2025.100979).

View Lab Material

L1-silenced iPSC line (HS1_L1HS-CRISPRi_g2 )

Human iPSCs were modified with CRISPRi to target LINE-1 retrotransposons, creating stable cell lines with different genetic backgrounds and guide RNAs. These resources are detailed in Adami et al. (DOI: 10.1016/j.xgen.2025.100979).

View Lab Material

L1-silenced iPSC line – Control (HS1_L1HS-CRISPRi_LacZ )

Human iPSCs were modified with CRISPRi to target LINE-1 retrotransposons, creating stable cell lines with different genetic backgrounds and guide RNAs. These resources are detailed in Adami et al. (DOI: 10.1016/j.xgen.2025.100979).

View Lab Material
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.